BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright: ©Author(s) 2026.
World J Psychiatry. Jul 19, 2026; 16(7): 117803
Published online Jul 19, 2026. doi: 10.5498/wjp.117803
Table 1 Baseline characteristics, mean ± SD

GAD group
Control group
P value
t/F
Age (years)35.00 ± 11.0233.65 ± 12.350.717-0.365
Gender (male/female)4/169/110.0881.000
Disease course (months)31.55 ± 20.62
HAMA23.95 ± 4.52
SAS55.69 ± 4.22
PSQI12.65 ± 3.588
Table 2 Comparison of primary and secondary outcome indicators, mean ± SD


Before treatment
After treatment
P value
t
PrimaryHAMA23.95 ± 4.529.75 ± 5.940.00013.33
SecondarySAS55.69 ± 4.2236.88 ± 6.700.00012.15
PSQI12.65 ± 3.596.05 ± 2.800.00010.08


Write to the Help Desk